Back to UBS Group AG UBS Group AG

ENTXENTX
29 quarters

Position history for UBS Group AGUBS Group AG's holdings in ENTERA BIO LTD

UBS Group AG holds 12,723 shares of ENTX (ENTERA BIO LTD), worth $22,520 as of 2026-Q2. The position was increased (+296.1% shares).

Current Value

$22,520

Current Shares

12,723

Total Value Change

+$17,520

Total Shares Change

+11,586

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
12,723
+296.1%
$22,5200.0%$1.77
21
2026-Q1
Increased
3,212
+188x
$3,5650.0%$1.34
15
2025-Q4
Decreased
17
-99.8%
$330.0%$2.00
0
2025-Q3
Decreased
10,452
-33.1%
$20,0680.0%$1.95
0
2025-Q2
New
15,631
-
$29,6990.0%$1.98
30
2024-Q4
Exited
0
-100.0%
$00.0%$2.18
0
2024-Q3
Decreased
142,747
-14.8%
$271,2200.0%$2.01
0
2024-Q2
Increased
167,623
+11.8%
$308,4260.0%$1.84
26
2024-Q1
New
149,869
-
$250,2810.0%$1.67
32
2023-Q4
Exited
0
-100.0%
$00.0%$0.60
0
2023-Q3
Decreased
614
-42.3%
$4450.0%$0.73
0
2023-Q2
Decreased
1,064
-89.1%
$8970.0%$0.82
0
2023-Q1
Decreased
9,740
-6.2%
$11,2980.0%$1.22
0
2022-Q4
Increased
10,388
+492.3%
$7,5830.0%$0.73
18
2022-Q3
Decreased
1,754
-76.3%
$2,0000.0%$1.05
0
2022-Q2
Increased
7,404
+58.9%
$10,0000.0%$1.34
17
2022-Q1
New
4,660
-
$13,0000.0%$2.79
27
2021-Q4
Exited
0
-100.0%
$00.0%$2.88
0
2021-Q3
Decreased
565
-44.7%
$3,0000.0%$4.89
0
2021-Q2
Decreased
1,022
-36.7%
$6,0000.0%$5.78
0
2021-Q1
Increased
1,614
+243.4%
$6,0000.0%$3.30
17
2020-Q4
Decreased
470
-94.0%
$1,0000.0%$1.10
0
2020-Q3
Decreased
7,838
-24.5%
$10,0000.0%$1.25
0
2020-Q2
New
10,382
-
$19,0000.0%$1.87
28
2020-Q1
Exited
0
-100.0%
$00.0%$2.06
0
2019-Q4
Increased
620
+33.3%
$1,0000.0%$2.05
10
2019-Q3
Decreased
465
-32.3%
$1,0000.0%$2.49
0
2019-Q2
Decreased
687
-39.6%
$2,0000.0%$3.43
0
2019-Q1
New
1,137
-
$5,0000.0%$4.32
23

Other major holders of ENTX: RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used